zoom_in Click to enlarge

Emmanuelle Charpentier

▲ ▼

description Emmanuelle Charpentier Overview

Emmanuelle Charpentier is a French microbiologist recognized globally for her pivotal role in developing the CRISPR-Cas9 gene editing technology. Her work, alongside Jennifer Doudna, revolutionized biological research and offers unprecedented tools for precise genetic modification. This discovery earned her a share of the 2020 Nobel Prize in Chemistry. Charpentier’s innovations are particularly valuable to scientists studying microbiology, genetics, and those involved in developing new therapies through targeted gene editing.

help Emmanuelle Charpentier FAQ

What did Emmanuelle Charpentier discover before CRISPR-Cas9 became famous?

Charpentier identified the role of tracrRNA in the bacterial CRISPR-Cas9 immune system. That insight helped make the system programmable for genome editing with Jennifer Doudna.

Why did Charpentier and Jennifer Doudna win the Nobel Prize?

They shared the 2020 Nobel Prize in Chemistry for developing a method for genome editing. Their CRISPR-Cas9 work gave researchers a way to target and cut DNA with high precision.

Was the key CRISPR paper before or after Charpentier met Doudna?

Charpentier and Doudna began collaborating after meeting in 2011. Their influential CRISPR-Cas9 paper appeared in 2012, before the technology rapidly spread through biology labs.

Where has Emmanuelle Charpentier worked in Germany?

Charpentier became a director at the Max Planck Institute for Infection Biology in Berlin. She later founded the Max Planck Unit for the Science of Pathogens.